Part 1
Part 2
Part 3
Part 4
Part 5
Description
The global market for Polystyrene Latex Particle for In-Vitro Diagnostics was estimated to be worth US$ 50.6 million in 2024 and is forecast to a readjusted size of US$ 73.3 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Latex particles, also known as latex microspheres, are small, spherical beads made from polystyrene that are typically used in a variety of in-vitro diagnostic (IVD) applications. These particles are widely employed due to their high surface area, uniform size, ease of functionalization, and ability to carry various reagents or biomolecules (e.g., antibodies, antigens, nucleic acids) for detecting specific analytes in biological samples.
Polystyrene Latex Particle for In-Vitro Diagnostics Market Size(US$)
M= millions and B=billions

Market Size and Growth:
The global in-vitro diagnostics (IVD) market, including polystyrene latex particles, is expected to grow steadily, driven by an increasing demand for point-of-care testing, disease diagnostics, and home care kits.
Technological Developments:
Advances in automation for both polystyrene latex particle production and the diagnostic processes (such as in high-throughput screening) are driving the adoption of latex-based tests, particularly in clinical labs and high-volume testing environments.
Competitive Landscape:
The market for polystyrene latex particles in diagnostics is highly competitive, with several large multinational companies dominating the market. However, there is also significant competition from specialized companies offering more tailored and niche solutions.
Aging Population:
The aging global population is leading to an increase in age-related diseases such as Alzheimer’s, diabetes, and cancer. As the elderly population grows, the demand for effective diagnostic solutions, including those based on polystyrene latex particles, will continue to rise.
This report aims to provide a comprehensive presentation of the global market for Polystyrene Latex Particle for In-Vitro Diagnostics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Polystyrene Latex Particle for In-Vitro Diagnostics by region & country, by Type, and by Application.
The Polystyrene Latex Particle for In-Vitro Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (Liters) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polystyrene Latex Particle for In-Vitro Diagnostics.
Market Segmentation
Report Metric
Details
Report Title
Polystyrene Latex Particle for In-Vitro Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Forecasted Market Size in 2031
US$ 73.3 million
CAGR(2025-2031)
5.5%
Market Size Available for Years
2025-2031
Global Polystyrene Latex Particle for In-Vitro Diagnostics Companies Covered
JSR Life Sciences
Merck
VDO Biotech
Bangs Laboratories
Thermo Fisher
Agilent
Fujikura Kasei
Suzhou NanoMicro
IKERLAT Polymers
Sunresin New Materials
Global Polystyrene Latex Particle for In-Vitro Diagnostics Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Polystyrene Latex Particle for In-Vitro Diagnostics Market, Segment by Type
Plain Latex Particles
Modified Latex Particles
Global Polystyrene Latex Particle for In-Vitro Diagnostics Market, Segment by Application
Latex Immunoturbidimetry
Latex Agglutination Test
Immunochromatography
Other
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Polystyrene Latex Particle for In-Vitro Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Polystyrene Latex Particle for In-Vitro Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Polystyrene Latex Particle for In-Vitro Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Polystyrene Latex Particle for In-Vitro Diagnostics Product Introduction
1.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Size Forecast
1.2.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value (2020-2031)
1.2.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume (2020-2031)
1.2.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Price (2020-2031)
1.3 Polystyrene Latex Particle for In-Vitro Diagnostics Market Trends & Drivers
1.3.1 Polystyrene Latex Particle for In-Vitro Diagnostics Industry Trends
1.3.2 Polystyrene Latex Particle for In-Vitro Diagnostics Market Drivers & Opportunity
1.3.3 Polystyrene Latex Particle for In-Vitro Diagnostics Market Challenges
1.3.4 Polystyrene Latex Particle for In-Vitro Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Players Revenue Ranking (2024)
2.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Company (2020-2025)
2.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Players Sales Volume Ranking (2024)
2.4 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Company Players (2020-2025)
2.5 Global Polystyrene Latex Particle for In-Vitro Diagnostics Average Price by Company (2020-2025)
2.6 Key Manufacturers Polystyrene Latex Particle for In-Vitro Diagnostics Manufacturing Base and Headquarters
2.7 Key Manufacturers Polystyrene Latex Particle for In-Vitro Diagnostics Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Polystyrene Latex Particle for In-Vitro Diagnostics
2.9 Polystyrene Latex Particle for In-Vitro Diagnostics Market Competitive Analysis
2.9.1 Polystyrene Latex Particle for In-Vitro Diagnostics Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Polystyrene Latex Particle for In-Vitro Diagnostics Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polystyrene Latex Particle for In-Vitro Diagnostics as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Plain Latex Particles
3.1.2 Modified Latex Particles
3.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type
3.2.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, by Type (2020-2031)
3.2.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, by Type (%) (2020-2031)
3.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Type
3.3.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume, by Type (2020-2031)
3.3.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume, by Type (%) (2020-2031)
3.4 Global Polystyrene Latex Particle for In-Vitro Diagnostics Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Latex Immunoturbidimetry
4.1.2 Latex Agglutination Test
4.1.3 Immunochromatography
4.1.4 Other
4.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application
4.2.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, by Application (2020-2031)
4.2.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, by Application (%) (2020-2031)
4.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Application
4.3.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume, by Application (2020-2031)
4.3.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume, by Application (%) (2020-2031)
4.4 Global Polystyrene Latex Particle for In-Vitro Diagnostics Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Region
5.1.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Region (2020-2025)
5.1.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Region (2026-2031)
5.1.4 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Region (%), (2020-2031)
5.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Region
5.2.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Region (2020-2025)
5.2.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Region (2026-2031)
5.2.4 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Region (%), (2020-2031)
5.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, 2020-2031
5.4.2 North America Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, 2020-2031
5.5.2 Europe Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, 2020-2031
5.6.2 Asia Pacific Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, 2020-2031
5.7.2 South America Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, 2020-2031
5.8.2 Middle East & Africa Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value and Sales Volume
6.2.1 Key Countries/Regions Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, 2020-2031
6.2.2 Key Countries/Regions Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, 2020-2031
6.3.2 United States Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, 2020-2031
6.4.2 Europe Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, 2020-2031
6.5.2 China Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (%), 2024 VS 2031
6.5.3 China Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, 2020-2031
6.6.2 Japan Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, 2020-2031
6.7.2 South Korea Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, 2020-2031
6.8.2 Southeast Asia Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, 2020-2031
6.9.2 India Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (%), 2024 VS 2031
6.9.3 India Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 JSR Life Sciences
7.1.1 JSR Life Sciences Company Information
7.1.2 JSR Life Sciences Introduction and Business Overview
7.1.3 JSR Life Sciences Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 JSR Life Sciences Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
7.1.5 JSR Life Sciences Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Introduction and Business Overview
7.2.3 Merck Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Merck Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
7.2.5 Merck Recent Development
7.3 VDO Biotech
7.3.1 VDO Biotech Company Information
7.3.2 VDO Biotech Introduction and Business Overview
7.3.3 VDO Biotech Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 VDO Biotech Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
7.3.5 VDO Biotech Recent Development
7.4 Bangs Laboratories
7.4.1 Bangs Laboratories Company Information
7.4.2 Bangs Laboratories Introduction and Business Overview
7.4.3 Bangs Laboratories Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Bangs Laboratories Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
7.4.5 Bangs Laboratories Recent Development
7.5 Thermo Fisher
7.5.1 Thermo Fisher Company Information
7.5.2 Thermo Fisher Introduction and Business Overview
7.5.3 Thermo Fisher Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Thermo Fisher Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
7.5.5 Thermo Fisher Recent Development
7.6 Agilent
7.6.1 Agilent Company Information
7.6.2 Agilent Introduction and Business Overview
7.6.3 Agilent Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Agilent Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
7.6.5 Agilent Recent Development
7.7 Fujikura Kasei
7.7.1 Fujikura Kasei Company Information
7.7.2 Fujikura Kasei Introduction and Business Overview
7.7.3 Fujikura Kasei Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Fujikura Kasei Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
7.7.5 Fujikura Kasei Recent Development
7.8 Suzhou NanoMicro
7.8.1 Suzhou NanoMicro Company Information
7.8.2 Suzhou NanoMicro Introduction and Business Overview
7.8.3 Suzhou NanoMicro Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Suzhou NanoMicro Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
7.8.5 Suzhou NanoMicro Recent Development
7.9 IKERLAT Polymers
7.9.1 IKERLAT Polymers Company Information
7.9.2 IKERLAT Polymers Introduction and Business Overview
7.9.3 IKERLAT Polymers Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 IKERLAT Polymers Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
7.9.5 IKERLAT Polymers Recent Development
7.10 Sunresin New Materials
7.10.1 Sunresin New Materials Company Information
7.10.2 Sunresin New Materials Introduction and Business Overview
7.10.3 Sunresin New Materials Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Sunresin New Materials Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
7.10.5 Sunresin New Materials Recent Development
8 Industry Chain Analysis
8.1 Polystyrene Latex Particle for In-Vitro Diagnostics Industrial Chain
8.2 Polystyrene Latex Particle for In-Vitro Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Polystyrene Latex Particle for In-Vitro Diagnostics Sales Model
8.5.2 Sales Channel
8.5.3 Polystyrene Latex Particle for In-Vitro Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Polystyrene Latex Particle for In-Vitro Diagnostics Market Trends
Table 2. Polystyrene Latex Particle for In-Vitro Diagnostics Market Drivers & Opportunity
Table 3. Polystyrene Latex Particle for In-Vitro Diagnostics Market Challenges
Table 4. Polystyrene Latex Particle for In-Vitro Diagnostics Market Restraints
Table 5. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Market Share by Company (2020-2025)
Table 7. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Company (2020-2025) & (Liters)
Table 8. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Polystyrene Latex Particle for In-Vitro Diagnostics Price by Company (2020-2025) & (US$/Liter)
Table 10. Key Manufacturers Polystyrene Latex Particle for In-Vitro Diagnostics Manufacturing Base and Headquarters
Table 11. Key Manufacturers Polystyrene Latex Particle for In-Vitro Diagnostics Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Polystyrene Latex Particle for In-Vitro Diagnostics
Table 13. Global Polystyrene Latex Particle for In-Vitro Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polystyrene Latex Particle for In-Vitro Diagnostics as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share in Value by Type (2020-2025)
Table 20. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share in Value by Type (2026-2031)
Table 21. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Type: 2020 VS 2024 VS 2031 (Liters)
Table 22. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Type (2020-2025) & (Liters)
Table 23. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Type (2026-2031) & (Liters)
Table 24. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Polystyrene Latex Particle for In-Vitro Diagnostics Price by Type (2020-2025) & (US$/Liter)
Table 27. Global Polystyrene Latex Particle for In-Vitro Diagnostics Price by Type (2026-2031) & (US$/Liter)
Table 28. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share in Value by Application (2020-2025)
Table 32. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share in Value by Application (2026-2031)
Table 33. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Application: 2020 VS 2024 VS 2031 (Liters)
Table 34. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Application (2020-2025) & (Liters)
Table 35. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Application (2026-2031) & (Liters)
Table 36. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Polystyrene Latex Particle for In-Vitro Diagnostics Price by Application (2020-2025) & (US$/Liter)
Table 39. Global Polystyrene Latex Particle for In-Vitro Diagnostics Price by Application (2026-2031) & (US$/Liter)
Table 40. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Region (2020-2025) & (%)
Table 44. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Region (2026-2031) & (%)
Table 45. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Region (Liters): 2020 VS 2024 VS 2031
Table 46. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Region (2020-2025) & (Liters)
Table 47. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Region (2026-2031) & (Liters)
Table 48. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Region (2020-2025) & (%)
Table 49. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Region (2026-2031) & (%)
Table 50. Global Polystyrene Latex Particle for In-Vitro Diagnostics Average Price by Region (2020-2025) & (US$/Liter)
Table 51. Global Polystyrene Latex Particle for In-Vitro Diagnostics Average Price by Region (2026-2031) & (US$/Liter)
Table 52. Key Countries/Regions Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume, (2020-2025) & (Liters)
Table 56. Key Countries/Regions Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume, (2026-2031) & (Liters)
Table 57. JSR Life Sciences Company Information
Table 58. JSR Life Sciences Introduction and Business Overview
Table 59. JSR Life Sciences Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter) and Gross Margin (2020-2025)
Table 60. JSR Life Sciences Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
Table 61. JSR Life Sciences Recent Development
Table 62. Merck Company Information
Table 63. Merck Introduction and Business Overview
Table 64. Merck Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter) and Gross Margin (2020-2025)
Table 65. Merck Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
Table 66. Merck Recent Development
Table 67. VDO Biotech Company Information
Table 68. VDO Biotech Introduction and Business Overview
Table 69. VDO Biotech Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter) and Gross Margin (2020-2025)
Table 70. VDO Biotech Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
Table 71. VDO Biotech Recent Development
Table 72. Bangs Laboratories Company Information
Table 73. Bangs Laboratories Introduction and Business Overview
Table 74. Bangs Laboratories Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter) and Gross Margin (2020-2025)
Table 75. Bangs Laboratories Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
Table 76. Bangs Laboratories Recent Development
Table 77. Thermo Fisher Company Information
Table 78. Thermo Fisher Introduction and Business Overview
Table 79. Thermo Fisher Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter) and Gross Margin (2020-2025)
Table 80. Thermo Fisher Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
Table 81. Thermo Fisher Recent Development
Table 82. Agilent Company Information
Table 83. Agilent Introduction and Business Overview
Table 84. Agilent Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter) and Gross Margin (2020-2025)
Table 85. Agilent Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
Table 86. Agilent Recent Development
Table 87. Fujikura Kasei Company Information
Table 88. Fujikura Kasei Introduction and Business Overview
Table 89. Fujikura Kasei Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter) and Gross Margin (2020-2025)
Table 90. Fujikura Kasei Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
Table 91. Fujikura Kasei Recent Development
Table 92. Suzhou NanoMicro Company Information
Table 93. Suzhou NanoMicro Introduction and Business Overview
Table 94. Suzhou NanoMicro Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter) and Gross Margin (2020-2025)
Table 95. Suzhou NanoMicro Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
Table 96. Suzhou NanoMicro Recent Development
Table 97. IKERLAT Polymers Company Information
Table 98. IKERLAT Polymers Introduction and Business Overview
Table 99. IKERLAT Polymers Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter) and Gross Margin (2020-2025)
Table 100. IKERLAT Polymers Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
Table 101. IKERLAT Polymers Recent Development
Table 102. Sunresin New Materials Company Information
Table 103. Sunresin New Materials Introduction and Business Overview
Table 104. Sunresin New Materials Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter) and Gross Margin (2020-2025)
Table 105. Sunresin New Materials Polystyrene Latex Particle for In-Vitro Diagnostics Product Offerings
Table 106. Sunresin New Materials Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Polystyrene Latex Particle for In-Vitro Diagnostics Downstream Customers
Table 110. Polystyrene Latex Particle for In-Vitro Diagnostics Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Polystyrene Latex Particle for In-Vitro Diagnostics Product Picture
Figure 2. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume (2020-2031) & (Liters)
Figure 5. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Price (2020-2031) & (US$/Liter)
Figure 6. Polystyrene Latex Particle for In-Vitro Diagnostics Report Years Considered
Figure 7. Global Polystyrene Latex Particle for In-Vitro Diagnostics Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Polystyrene Latex Particle for In-Vitro Diagnostics Players Sales Volume Ranking (2024) & (Liters)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Polystyrene Latex Particle for In-Vitro Diagnostics Revenue in 2024
Figure 10. Polystyrene Latex Particle for In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Plain Latex Particles Picture
Figure 12. Modified Latex Particles Picture
Figure 13. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Type (2020 VS 2024 VS 2031) & (Liters)
Figure 16. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Polystyrene Latex Particle for In-Vitro Diagnostics Price by Type (2020-2031) & (US$/Liter)
Figure 18. Product Picture of Latex Immunoturbidimetry
Figure 19. Product Picture of Latex Agglutination Test
Figure 20. Product Picture of Immunochromatography
Figure 21. Product Picture of Other
Figure 22. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 23. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value Market Share by Application, 2024 & 2031
Figure 24. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume by Application (2020 VS 2024 VS 2031) & (Liters)
Figure 25. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume Market Share by Application, 2024 & 2031
Figure 26. Global Polystyrene Latex Particle for In-Vitro Diagnostics Price by Application (2020-2031) & (US$/Liter)
Figure 27. North America Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value (2020-2031) & (US$ Million)
Figure 28. North America Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Country (%), 2024 VS 2031
Figure 29. Europe Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, (2020-2031) & (US$ Million)
Figure 30. Europe Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Country (%), 2024 VS 2031
Figure 31. Asia Pacific Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Region (%), 2024 VS 2031
Figure 33. South America Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, (2020-2031) & (US$ Million)
Figure 34. South America Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Country (%), 2024 VS 2031
Figure 35. Middle East & Africa Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, (2020-2031) & (US$ Million)
Figure 36. Middle East & Africa Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Country (%), 2024 VS 2031
Figure 37. Key Countries/Regions Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value (%), (2020-2031)
Figure 38. Key Countries/Regions Polystyrene Latex Particle for In-Vitro Diagnostics Sales Volume (%), (2020-2031)
Figure 39. United States Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, (2020-2031) & (US$ Million)
Figure 40. United States Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (%), 2024 VS 2031
Figure 41. United States Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application (%), 2024 VS 2031
Figure 42. Europe Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, (2020-2031) & (US$ Million)
Figure 43. Europe Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (%), 2024 VS 2031
Figure 44. Europe Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application (%), 2024 VS 2031
Figure 45. China Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, (2020-2031) & (US$ Million)
Figure 46. China Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (%), 2024 VS 2031
Figure 47. China Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application (%), 2024 VS 2031
Figure 48. Japan Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, (2020-2031) & (US$ Million)
Figure 49. Japan Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (%), 2024 VS 2031
Figure 50. Japan Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application (%), 2024 VS 2031
Figure 51. South Korea Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, (2020-2031) & (US$ Million)
Figure 52. South Korea Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (%), 2024 VS 2031
Figure 53. South Korea Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application (%), 2024 VS 2031
Figure 54. Southeast Asia Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, (2020-2031) & (US$ Million)
Figure 55. Southeast Asia Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (%), 2024 VS 2031
Figure 56. Southeast Asia Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application (%), 2024 VS 2031
Figure 57. India Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value, (2020-2031) & (US$ Million)
Figure 58. India Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Type (%), 2024 VS 2031
Figure 59. India Polystyrene Latex Particle for In-Vitro Diagnostics Sales Value by Application (%), 2024 VS 2031
Figure 60. Polystyrene Latex Particle for In-Vitro Diagnostics Industrial Chain
Figure 61. Polystyrene Latex Particle for In-Vitro Diagnostics Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives InterviewedDescription
The global market for Polystyrene Latex Particle for In-Vitro Diagnostics was estimated to be worth US$ 50.6 million in 2024 and is forecast to a readjusted size of US$ 73.3 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Latex particles, also known as latex microspheres, are small, spherical beads made from polystyrene that are typically used in a variety of in-vitro diagnostic (IVD) applications. These particles are widely employed due to their high surface area, uniform size, ease of functionalization, and ability to carry various reagents or biomolecules (e.g., antibodies, antigens, nucleic acids) for detecting specific analytes in biological samples.
Market Size and Growth:
The global in-vitro diagnostics (IVD) market, including polystyrene latex particles, is expected to grow steadily, driven by an increasing demand for point-of-care testing, disease diagnostics, and home care kits.
Technological Developments:
Advances in automation for both polystyrene latex particle production and the diagnostic processes (such as in high-throughput screening) are driving the adoption of latex-based tests, particularly in clinical labs and high-volume testing environments.
Competitive Landscape:
The market for polystyrene latex particles in diagnostics is highly competitive, with several large multinational companies dominating the market. However, there is also significant competition from specialized companies offering more tailored and niche solutions.
Aging Population:
The aging global population is leading to an increase in age-related diseases such as Alzheimer’s, diabetes, and cancer. As the elderly population grows, the demand for effective diagnostic solutions, including those based on polystyrene latex particles, will continue to rise.
This report aims to provide a comprehensive presentation of the global market for Polystyrene Latex Particle for In-Vitro Diagnostics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Polystyrene Latex Particle for In-Vitro Diagnostics by region & country, by Type, and by Application.
The Polystyrene Latex Particle for In-Vitro Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (Liters) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polystyrene Latex Particle for In-Vitro Diagnostics.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Polystyrene Latex Particle for In-Vitro Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Polystyrene Latex Particle for In-Vitro Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Polystyrene Latex Particle for In-Vitro Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Related Reports
The global market for Polystyrene Latex Particle for In-Vitro Diagnostics was valued at US$ 48.7 million in the year 2023 and is projected to reach a revised size of US$ 69.8 million by 2030, growing at a CAGR of 5.5% during the forecast period.
Published: 2024-12-22
Pages: 82
USD 2900.00
(Single User License)
Valued at US$ 50.6 million in 2024, the global Polystyrene Latex Particle for In-Vitro Diagnostics market is forecast to reach US$ 69.8 million by 2030, at a CAGR of 5.5% during the forecast period.
Published: 2024-12-22
Pages: 144
USD 4900.00
(Single User License)
The global Polystyrene Latex Particle for In-Vitro Diagnostics revenue was US$ 48.7 million in 2023 and is forecast to a readjusted size of US$ 69.8 million by 2030 with a CAGR of 5.5% during the review period (2024-2030).
Published: 2024-12-22
Pages: 116
USD 4350.00
(Single User License)
The global market for Polystyrene Latex Particle for In-Vitro Diagnostics was valued at US$ 50.6 million in the year 2024 and is projected to reach a revised size of US$ 73.3 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published: 2025-03-10
Pages: 78
USD 2900.00
(Single User License)
The global Polystyrene Latex Particle for In-Vitro Diagnostics market size was US$ 50.6 million in 2024 and is forecast to a readjusted size of US$ 73.3 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 80
USD 4250.00
(Single User License)
The global Polystyrene Latex Particle for In-Vitro Diagnostics market is projected to grow from US$ 50.6 million in 2024 to US$ 73.3 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 135
USD 4900.00
(Single User License)
The global Polystyrene Latex Particle for In-Vitro Diagnostics market was valued at US$ 53.13 million in 2025 and is anticipated to reach US$ 76.88 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 114
USD 2900.00
(Single User License)
The global market for Polystyrene Latex Particle for In-Vitro Diagnostics was estimated to be worth US$ 53.13 million in 2025 and is projected to reach US$ 76.88 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 95
USD 3950.00
(Single User License)
The global Polystyrene Latex Particle for In-Vitro Diagnostics market size was US$ 53.13 million in 2025 and is forecast to reach a readjusted size of US$ 76.88 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 79
USD 4250.00
(Single User License)
The global Polystyrene Latex Particle for In-Vitro Diagnostics market is projected to grow from US$ 53.13 million in 2025 to US$ 76.88 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 149
USD 4900.00
(Single User License)
The global market for Polystyrene Latex Particle for In-Vitro Diagnostics was valued at US$ 48.7 million in the year 2023 and is projected to reach a revised size of US$ 69.8 million by 2030, growing at a CAGR of 5.5% during the forecast period.
Published: 2024-12-22
Pages: 82
Valued at US$ 50.6 million in 2024, the global Polystyrene Latex Particle for In-Vitro Diagnostics market is forecast to reach US$ 69.8 million by 2030, at a CAGR of 5.5% during the forecast period.
Published: 2024-12-22
Pages: 144
The global Polystyrene Latex Particle for In-Vitro Diagnostics revenue was US$ 48.7 million in 2023 and is forecast to a readjusted size of US$ 69.8 million by 2030 with a CAGR of 5.5% during the review period (2024-2030).
Published: 2024-12-22
Pages: 116
The global market for Polystyrene Latex Particle for In-Vitro Diagnostics was valued at US$ 50.6 million in the year 2024 and is projected to reach a revised size of US$ 73.3 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published: 2025-03-10
Pages: 78
The global Polystyrene Latex Particle for In-Vitro Diagnostics market size was US$ 50.6 million in 2024 and is forecast to a readjusted size of US$ 73.3 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 80
The global Polystyrene Latex Particle for In-Vitro Diagnostics market is projected to grow from US$ 50.6 million in 2024 to US$ 73.3 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 135
The global Polystyrene Latex Particle for In-Vitro Diagnostics market was valued at US$ 53.13 million in 2025 and is anticipated to reach US$ 76.88 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 114
The global market for Polystyrene Latex Particle for In-Vitro Diagnostics was estimated to be worth US$ 53.13 million in 2025 and is projected to reach US$ 76.88 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-09
Pages: 95
The global Polystyrene Latex Particle for In-Vitro Diagnostics market size was US$ 53.13 million in 2025 and is forecast to reach a readjusted size of US$ 76.88 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 79
The global Polystyrene Latex Particle for In-Vitro Diagnostics market is projected to grow from US$ 53.13 million in 2025 to US$ 76.88 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 149
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database